ArticleFrontiers in psychiatry2024
Near-infrared spectroscopy-guided personalized repetitive transcranial magnetic stimulation for bipolar depression: a case report.
Article in Frontiers in psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- An update on the effects of cerebellar transcranial magnetic stimulation on cognitive function.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026Review
- [Prefrontal dysfunction and mismatch negativity in adolescent depression: A multimodal fNIRS-ERP study].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Transcranial magnetic stimulation (TMS) is a common treatment for depression, particularly in patients unresponsive to conventional therapies. High-frequency (10 Hz), low-frequency (1 Hz), or bilateral (left, high-frequency; right, low-frequency) stimulation of the dorsolateral prefrontal cortex (DLPFC) has been demonstrated to be effective in studies based on prefrontal asymmetry theory, which suggests that depression is associated with reduced left frontal function and increased right frontal function. However, few reliable predictors or biomarkers are available for personalizing treatment protocols on the basis of a patient's brain function. Near-infrared spectroscopy (NIRS), a noninvasive neuroimaging tool that assesses functional changes in the brain during cognitive tasks, can measure a patient's bilateral frontal lobe function in real time. Thus, this tool can aid the development of personalized TMS protocols for patients with depression. Methods: A 19-year-old woman presented to our psychiatric clinic with bipolar depression. NIRS was performed to select an appropriate TMS protocol for the patient. A verbal fluency test revealed bilateral low frontal lobe function. Thus, we selected a TMS protocol involving 10 sessions of bilateral high-frequency stimulation over 4 days, with each session delivering 3000 pulses on each side of the DLPFC. Results: Before treatment, the patient's scores on the Hamilton Depression Rating Scale (HAMD), Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), and Young Mania Rating Scale were 40, 57, 40, and 6, respectively. After treatment, her depressive symptoms substantially improved, with HAMD, BDI, and BAI scores decreasing to 17, 21, and 14, respectively. Although the treatment led to side effects such as dizziness and headache, these effects resolved after the treatment. At the 6-month follow-up, the patient's condition was still stable, with HAMD, BDI, and BAI scores of 10, 13, and 7, respectively. Conclusion: Our case suggests that NIRS can guide the selection of appropriate TMS protocols for patients with bipolar depression. Although our findings are promising, further randomized controlled trials are needed to validate the efficacy and safety of and determine the optimal parameters for this approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.